A randomized, double-blind, multi-center, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of subjects with knee osteoarthritis

Trial Profile

A randomized, double-blind, multi-center, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of subjects with knee osteoarthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Calcitonin (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors Nordic Bioscience
  • Most Recent Events

    • 08 Nov 2017 Results of post-hoc analysis using pooled pre-treatment baseline data of two phase III studies (NCT00486434 and NCT00704847), presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific.
    • 13 Jun 2015 Results (pooled analysis of CSMC021C2301 and CSMC021C2302) presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 10 Jun 2015 Post-hoc analysis (of trails NCT00486434 and NCT00704847) as per abstract presented at 16th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top